Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

The balance between IL-1 and IL-1Ra in disease.

Arend WP.

Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):323-40. Review.

PMID:
12220547
2.
3.

Interleukin-1 receptor antagonist.

Lennard AC.

Crit Rev Immunol. 1995;15(1):77-105. Review.

PMID:
8519423
4.

Interleukin-1 receptor antagonist gene therapy for arthritis.

Krishnan BR.

Curr Opin Mol Ther. 1999 Aug;1(4):454-7. Review.

PMID:
11713759
5.

Biologic basis for interleukin-1 in disease.

Dinarello CA.

Blood. 1996 Mar 15;87(6):2095-147. Review.

6.

Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.

Ricote M, García-Tuñón I, Bethencourt FR, Fraile B, Paniagua R, Royuela M.

Cancer. 2004 Apr 1;100(7):1388-96.

7.

In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.

Ricci S, Macchia G, Ruggiero P, Maggi T, Bossù P, Xu L, Medaglini D, Tagliabue A, Hammarström L, Pozzi G, Boraschi D.

BMC Biotechnol. 2003 Sep 17;3:15. Epub 2003 Sep 17.

8.

Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.

Hur W, Cho ML, Yoon SK, Kim SY, Ju JH, Jhun JY, Heo SB, Moon YM, Min SY, Park SH, Kim HY.

Immunol Lett. 2006 Aug 15;106(2):154-62. Epub 2006 Jun 5.

PMID:
16793145
9.
10.
11.

Biological role of interleukin 1 receptor antagonist isoforms.

Arend WP, Guthridge CJ.

Ann Rheum Dis. 2000 Nov;59 Suppl 1:i60-4. Review.

12.

Interleukin-1 receptor antagonist: role in biology.

Arend WP, Malyak M, Guthridge CJ, Gabay C.

Annu Rev Immunol. 1998;16:27-55. Review.

PMID:
9597123
13.

Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.

Somm E, Cettour-Rose P, Asensio C, Charollais A, Klein M, Theander-Carrillo C, Juge-Aubry CE, Dayer JM, Nicklin MJ, Meda P, Rohner-Jeanrenaud F, Meier CA.

Diabetologia. 2006 Feb;49(2):387-93. Epub 2005 Dec 30.

PMID:
16385385
14.

Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.

Ruggiero P, Bossù P, Macchia G, Del Grosso E, Sabbatini V, Bertini R, Colagrande A, Bizzarri C, Maurizi G, Di Cioccio V, D'Andrea G, Di Giulio A, Frigerio F, Grifantini R, Grandi G, Tagliabue A, Boraschi D.

J Immunol. 1997 Apr 15;158(8):3881-7.

PMID:
9103457
15.

Treatment of rheumatoid arthritis with IL-1 inhibitors.

Gabay C, Arend WP.

Springer Semin Immunopathol. 1998;20(1-2):229-46. Review.

PMID:
9836379
16.

Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease.

Thompson RC, Dripps DJ, Eisenberg SP.

Int J Immunopharmacol. 1992 Apr;14(3):475-80. Review.

PMID:
1535616
17.

The interleukin-1 receptor antagonist and its delivery by gene transfer.

Evans CH, Robbins PD.

Receptor. 1994 Spring;4(1):9-15. Review.

PMID:
8038709
18.

Differential expression of interleukin 1 receptor antagonist isoforms in human intestinal epithelial cells.

Böcker U, Damião A, Holt L, Han DS, Jobin C, Panja A, Mayer L, Sartor RB.

Gastroenterology. 1998 Dec;115(6):1426-38.

PMID:
9834270
19.
20.

Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.

Yamada J, Dana MR, Sotozono C, Kinoshita S.

Exp Eye Res. 2003 Feb;76(2):161-7.

PMID:
12565803

Supplemental Content

Support Center